Table 3

Early versus late recurrences among patients recurring within 36 months according to clinical and pathological characteristics

CharacteristicRecurrence
None (n = 36)Early (within 1–16 months; n = 13)Late (after 16 months; n = 12)
No.No.ORa (95% CI)No.OR (95% CI)
Age
 ≤65a2188
 >651550.9 (0.24–3.25)40.7 (0.18–2.79)
Gender
 Femaleb1620
 Male20114.4 (0.91–21.25)1220.1 (1.11–365.73)c
Chemotherapy
 Nob2242
 Yes1493.5 (0.91–13.71)107.8 (1.49–41.30)
Stage
 I–IIb2314
 III12611.5 (1.23–106.85)52.4 (0.54–10.61)
 IV16138.0 (7.49–2542.86)317.2 (1.41–210.12)
Differentiation of carcinoma
 Wellb1011
 Moderate or poor26124.6 (0.53–40.28)114.2 (0.48–37.17)
MYCL1
 LOH (−)2757
 LOH (+)1421.6 (1.97–235.74)415.4 (1.48–160.76)
14-3-3-σ-TG
 LOH (−)b1642
 LOH (+)455.0 (0.90–27.68)24.0 (0.42–37.78)
  • a OR, odds ratio; CI, confidence interval.

  • b Referent.

  • c Logit confidence limits were calculated because of zero cell.